These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31814314)

  • 1. RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.
    Mendes MI; Green LMC; Bertini E; Tonduti D; Aiello C; Smith D; Salsano E; Beerepoot S; Hertecant J; von Spiczak S; Livingston JH; Emrick L; Fraser J; Russell L; Bernard G; Magri S; Di Bella D; Taroni F; Koenig MK; Moroni I; Cappuccio G; Brunetti-Pierri N; Rhee J; Mendelsohn BA; Helbig I; Helbig K; Muhle H; Ismayl O; Vanderver AL; Salomons GS; van der Knaap MS; Wolf NI
    Ann Clin Transl Neurol; 2020 Jan; 7(1):83-93. PubMed ID: 31814314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RARS1-related hypomyelinating leukodystrophy-9 (HLD-9) in two distinct Iranian families: Case report and literature review.
    Biglari S; Vahidnezhad H; Tabatabaiefar MA; Khorram Khorshid HR; Esmaeilzadeh E
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2435. PubMed ID: 38618971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RARS1-related developmental and epileptic encephalopathy.
    Wan L; Yu D; Li Z; Liu X; Liang Y; Yan H; Zhu G; Zhang B; Yang G
    Epilepsia Open; 2023 Sep; 8(3):867-876. PubMed ID: 37186453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in RARS cause hypomyelination.
    Wolf NI; Salomons GS; Rodenburg RJ; Pouwels PJ; Schieving JH; Derks TG; Fock JM; Rump P; van Beek DM; van der Knaap MS; Waisfisz Q
    Ann Neurol; 2014 Jul; 76(1):134-9. PubMed ID: 24777941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy.
    Simons C; Dyment D; Bent SJ; Crawford J; D'Hooghe M; Kohlschütter A; Venkateswaran S; Helman G; Poll-The BT; Makowski CC; Ito Y; Kernohan K; Hartley T; Waisfisz Q; Taft RJ; ; van der Knaap MS; Wolf NI
    Brain; 2017 Dec; 140(12):3105-3111. PubMed ID: 29186371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.
    Li G; Eriani G; Wang ED; Zhou XL
    Sci China Life Sci; 2021 Oct; 64(10):1645-1660. PubMed ID: 33515434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.
    Ji H; Li D; Wu Y; Zhang Q; Gu Q; Xie H; Ji T; Wang H; Zhao L; Zhao H; Yang Y; Feng H; Xiong H; Ji J; Yang Z; Kou L; Li M; Bao X; Chang X; Zhang Y; Li L; Li H; Niu Z; Wu X; Xiao J; Jiang Y; Wang J
    PLoS One; 2018; 13(2):e0188869. PubMed ID: 29451896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10.
    Manaspon C; Boonsimma P; Phokaew C; Theerapanon T; Sriwattanapong K; Porntaveetus T; Shotelersuk V
    Am J Med Genet A; 2021 Oct; 185(10):3068-3073. PubMed ID: 34037307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.
    Curiel J; Rodríguez Bey G; Takanohashi A; Bugiani M; Fu X; Wolf NI; Nmezi B; Schiffmann R; Bugaighis M; Pierson T; Helman G; Simons C; van der Knaap MS; Liu J; Padiath Q; Vanderver A
    Hum Mol Genet; 2017 Nov; 26(22):4506-4518. PubMed ID: 28973395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating Leukodystrophy.
    Helman G; Zerem A; Almad A; Hacker JL; Woidill S; Sase S; LeFevre AN; Ekstein J; Johansson MM; Stutterd CA; Taft RJ; Simons C; Grinspan JB; Pizzino A; Schmidt JL; Harding B; Hirsch Y; Viaene AN; Fattal-Valevski A; Vanderver A
    Pediatr Neurol; 2021 Aug; 121():11-19. PubMed ID: 34111619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy.
    Mendes MI; Gutierrez Salazar M; Guerrero K; Thiffault I; Salomons GS; Gauquelin L; Tran LT; Forget D; Gauthier MS; Waisfisz Q; Smith DEC; Simons C; van der Knaap MS; Marquardt I; Lemes A; Mierzewska H; Weschke B; Koehler W; Coulombe B; Wolf NI; Bernard G
    Am J Hum Genet; 2018 Apr; 102(4):676-684. PubMed ID: 29576217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent de novo
    Cömert C; Brick L; Ang D; Palmfeldt J; Meaney BF; Kozenko M; Georgopoulos C; Fernandez-Guerra P; Bross P
    Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POLR3A variants in striatal involvement without diffuse hypomyelination.
    Hiraide T; Kubota K; Kono Y; Watanabe S; Matsubayashi T; Nakashima M; Kaname T; Fukao T; Shimozawa N; Ogata T; Saitsu H
    Brain Dev; 2020 Apr; 42(4):363-368. PubMed ID: 31932101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations.
    Roux CJ; Barcia G; Schiff M; Sissler M; Levy R; Dangouloff-Ros V; Desguerre I; Edvardson S; Elpeleg O; Rötig A; Munnich A; Boddaert N
    Mol Genet Metab; 2021 Jun; 133(2):222-229. PubMed ID: 33972171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megalencephalic leukoencephalopathy with subcortical cysts: Characterization of disease variants.
    Hamilton EMC; Tekturk P; Cialdella F; van Rappard DF; Wolf NI; Yalcinkaya C; Çetinçelik Ü; Rajaee A; Kariminejad A; Paprocka J; Yapici Z; Bošnjak VM; van der Knaap MS;
    Neurology; 2018 Apr; 90(16):e1395-e1403. PubMed ID: 29661901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy.
    Verdura E; Rodríguez-Palmero A; Vélez-Santamaria V; Planas-Serra L; de la Calle I; Raspall-Chaure M; Roubertie A; Benkirane M; Saettini F; Pavinato L; Mandrile G; O'Leary M; O'Heir E; Barredo E; Chacón A; Michaud V; Goizet C; Ruiz M; Schlüter A; Rouvet I; Sala-Coromina J; Fossati C; Iascone M; Canonico F; Marcé-Grau A; de Souza P; Adams DR; Casasnovas C; Rehm HL; Mefford HC; González Gutierrez-Solana L; Brusco A; Koenig M; Macaya A; Pujol A
    Brain; 2021 Oct; 144(9):2659-2669. PubMed ID: 34415322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUBB4A de novo mutations cause isolated hypomyelination.
    Pizzino A; Pierson TM; Guo Y; Helman G; Fortini S; Guerrero K; Saitta S; Murphy JL; Padiath Q; Xie Y; Hakonarson H; Xu X; Funari T; Fox M; Taft RJ; van der Knaap MS; Bernard G; Schiffmann R; Simons C; Vanderver A
    Neurology; 2014 Sep; 83(10):898-902. PubMed ID: 25085639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous variants in pyrroline-5-carboxylate reductase 2 (PYCR2) in patients with progressive microcephaly and hypomyelinating leukodystrophy.
    Meng L; Donti T; Xia F; Niu Z; Al Shamsi A; Hertecant J; Al-Jasmi F; Gibson JB; Nagakura H; Zhang J; He W; Eng C; Yang Y; Elsea SH
    Am J Med Genet A; 2017 Feb; 173(2):460-470. PubMed ID: 27860360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.
    Campopiano R; Ferese R; Zampatti S; Giardina E; Biagioni F; Colonnese C; Centonze D; Storto M; Buttari F; Fraviga E; Broccoli V; Fanelli M; Fornai F; Gambardella S
    BMC Neurol; 2020 Jun; 20(1):258. PubMed ID: 32600288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset autosomal dominant leukodystrophy without early autonomic dysfunctions linked to lamin B1 duplication: a phenotypic variant.
    Potic A; Pavlovic AM; Uziel G; Kozic D; Ostojic J; Rovelli A; Sternic N; Bjelan M; Sarto E; Di Bella D; Taroni F
    J Neurol; 2013 Aug; 260(8):2124-9. PubMed ID: 23681646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.